```json { "slots": [ { "scope": "dataset", "slot": "nature", "value": { "nature": "observational" }, "evidence": { "reasoning": "This is a clinical trial dataset (CDISCPILOT01) recording adverse events and subject demographics. The data measures phenomena (adverse events, patient characteristics, treatment outcomes) that researchers observe but do not control. While treatment assignment is controlled, the outcomes being measured—adverse events, completion status, deaths—are observed responses, not operational processes the data producer runs." } }, { "scope": "dataset", "slot": "decisions_served", "value": { "decisions": [ "Whether to advance Xanomeline to next trial phase based on safety profile", "Which adverse events require protocol amendments or additional monitoring", "Whether specific patient subgroups (age, race, sex) show differential safety signals", "Which sites require additional training or oversight based on adverse event reporting patterns", "Whether treatment discontinuation rates warrant dose adjustments" ] }, "evidence": { "reasoning": "The dataset tracks treatment arms (Placebo, Xanomeline Low Dose, Xanomeline High Dose), adverse events with severity and causality assessments, and completion status. These support go/no-go decisions on drug development, safety monitoring decisions during the trial, and protocol modification decisions." } }, { "scope": "dataset", "slot": "levers", "value": { "levers": [] }, "evidence": { "reasoning": "This is observational clinical trial data. While investigators control treatment assignment, the data itself records outcomes that cannot be directly manipulated—adverse events occur or don't occur, patients complete or discontinue. The levers (dose selection, enrollment criteria) were pulled before data collection; this dataset measures their effects." } }, { "scope": "dataset", "slot": "audience", "value": { "audience": [ "Clinical trial safety monitors", "Medical monitors and physicians", "Regulatory affairs specialists", "Biostatisticians", "Clinical operations managers", "Site investigators" ] }, "evidence": { "reasoning": "The dataset contains safety data (adverse events, deaths, serious events), treatment assignment, and completion status. These serve safety monitoring teams who assess ongoing risk, statisticians who analyze efficacy and safety, regulatory specialists who prepare submissions, and site staff who manage patient care." } }, { "scope": "table:adsl", "slot": "role", "value": { "role": "spine" }, "evidence": { "reasoning": "The derived role of 'fact' is incorrect. ADSL (Analysis Dataset Subject Level) is the subject-level spine in CDISC standards—one row per subject (USUBJID is unique), containing demographics, treatment assignments, and study milestones. It serves as the dimensional backbone that other event-level tables (like ae) join to for analysis." } }, { "scope": "table:adsl", "slot": "grain", "value": { "unit": "one row per study subject", "key_columns": ["USUBJID"] }, "evidence": { "reasoning": "USUBJID (Unique Subject Identifier) has uniqueness 1.0 and is tagged as primary_key. Each row represents one subject's complete study participation across all timepoints, containing their baseline characteristics, treatment assignment, and study outcome." } }, { "scope": "table:adsl", "slot": "temporal_posture", "value": { "posture": "typed", "columns": ["RFSTDTC", "RFENDTC", "RFXSTDTC", "RFXENDTC", "DTHDTC", "DMDTC", "TRTSDTM", "TRTEDTM", "TRTSDT", "TRTEDT", "SCRFDT", "EOSDT", "FRVDT", "RANDDT", "DTHDT", "LSTALVDT"] }, "evidence": { "reasoning": "The derived temporal_posture correctly identifies typed temporal columns. These represent study milestones: reference start/end dates (RF*), treatment start/end (TRT*), randomization (RANDDT), end of study (EOSDT), death dates (DTHDT), and last alive date (LSTALVDT). This is a cross-sectional summary with milestone dates, not a time series." } }, { "scope": "table:ae", "slot": "grain", "value": { "unit": "one row per adverse event occurrence per subject", "key_columns": ["USUBJID", "AESEQ"] }, "evidence": { "reasoning": "The composite key (USUBJID, AESEQ) is tagged as primary_key. USUBJID identifies the subject (225 unique values across 1191 rows), and AESEQ is the adverse event sequence number within that subject. Each row represents one distinct adverse event episode." } }, { "scope": "table:ae", "slot": "temporal_posture", "value": { "posture": "typed", "columns": ["AEDTC", "AESTDTC", "AEENDTC"] }, "evidence": { "reasoning": "The derived temporal_posture is correct. AEDTC (adverse event date), AESTDTC (start date), and AEENDTC (end date) are typed temporal columns. AEDTC has high uniqueness (0.3804) and monotonicity (0.4891), indicating it sequences events. AESTDTC and AEENDTC define the event duration window." } }, { "scope": "table:ae", "slot": "column_bindings", "value": { "bindings": [ {"column": "STUDYID", "binding": "identifier"}, {"column": "USUBJID", "binding": "identifier"}, {"column": "AESEQ", "binding": "identifier"}, {"column": "AESPID", "binding": "identifier"}, {"column": "AETERM", "binding": "category"}, {"column": "AEDECOD", "binding": "category"}, {"column": "AEBODSYS", "binding": "category"}, {"column": "AESOC", "binding": "category"}, {"column": "AESEV", "binding": "category"}, {"column": "AESER", "binding": "flag"}, {"column": "AEREL", "binding": "category"}, {"column": "AEOUT", "binding": "category"}, {"column": "AESCAN", "binding": "flag"}, {"column": "AESDISAB", "binding": "flag"}, {"column": "AESDTH", "binding": "flag"}, {"column": "AESHOSP", "binding": "flag"}, {"column": "AESLIFE", "binding": "flag"}, {"column": "AEDTC", "binding": "temporal"}, {"column": "AESTDTC", "binding": "temporal"}, {"column": "AEENDTC", "binding": "temporal"}, {"column": "AESTDY", "binding": "measure"}, {"column": "AEENDY", "binding": "measure"} ] }, "evidence": { "reasoning": "Refining derived bindings: AESER, AESCAN, AESDISAB, AESDTH, AESHOSP, AESLIFE are Y/N flags indicating serious event, scan required, disability, death, hospitalization, life-threatening—these are flags, not generic categories. AESTDY and AEENDY are study day offsets (numeric measures of time relative to treatment start), not categories. Other bindings are correct." } } ] } ```